BioCorRx Inc. (BICX) stock
BICXOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31
$0.25+0.00 (0.00%)
Close on Oct 19, 2026Market cap $7.30MP/E –Yield –
BioCorRx gross margin
Gross margin is gross profit as a percentage of revenue.
BioCorRx's gross margin for the twelve months ending Jun 30, 2025 was 100.0%. For fiscal 2024 it was 78.3%, against 59.6% the year before. The highest annual figure on record is 92.9% in fiscal 2022.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 78.3% | +18.6 |
| FY2023 | Dec 31, 2023 | 59.6% | −33.2 |
| FY2022 | Dec 31, 2022 | 92.9% | +5.0 |
| FY2021 | Dec 31, 2021 | 87.8% | +66.1 |
| FY2020 | Dec 31, 2020 | 21.8% | −44.3 |
| FY2019 | Dec 31, 2019 | 66.0% | +11.4 |
| FY2018 | Dec 31, 2018 | 54.6% | +3.8 |
| FY2017 | Dec 31, 2017 | 50.8% | −24.2 |
| FY2016 | Dec 31, 2016 | 75.0% | −8.6 |
| FY2015 | Dec 31, 2015 | 83.6% | +2.4 |
| FY2014 | Dec 31, 2014 | 81.1% | +3.5 |
| FY2013 | Dec 31, 2013 | 77.6% | +24.0 |
| FY2012 | Dec 31, 2012 | 53.6% | +5.5 |
| FY2011 | Dec 31, 2011 | 48.1% | +56.3 |
| FY2010 | Dec 31, 2010 | -8.2% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -64.8% | −164.8 |
| Q1 FY2026 | Mar 31, 2026 | 88.3% | +34.3 |
| Q2 FY2025 | Jun 30, 2025 | 100.0% | +68.9 |
| Q1 FY2025 | Mar 31, 2025 | 100.0% | +38.3 |
| Q2 FY2024 | Jun 30, 2024 | 100.0% | +52.8 |
| Q1 FY2024 | Mar 31, 2024 | 54.0% | −24.6 |
| Q4 FY2023 | Dec 31, 2023 | 31.1% | −61.4 |
| Q3 FY2023 | Sep 30, 2023 | 61.7% | −26.8 |
| Q2 FY2023 | Jun 30, 2023 | 47.2% | −46.6 |
| Q1 FY2023 | Mar 31, 2023 | 78.5% | +108.8 |
| Q1 FY2022 | Mar 31, 2022 | 92.5% | +48.0 |
| Q2 FY2021 | Sep 30, 2021 | 88.5% | +70.2 |
| Q1 FY2021 | Mar 31, 2021 | 93.8% | +55.9 |
| Q4 FY2020 | Dec 31, 2020 | -30.3% | −88.4 |
| Q3 FY2020 | Sep 30, 2020 | 44.5% | −7.6 |
| Q2 FY2020 | Jun 30, 2020 | 18.4% | −35.6 |
| Q1 FY2020 | Mar 31, 2020 | 37.8% | −57.8 |
| Q4 FY2019 | Dec 31, 2019 | 58.1% | +83.0 |
| Q3 FY2019 | Sep 30, 2019 | 52.1% | −21.7 |
| Q2 FY2019 | Jun 30, 2019 | 54.0% | +7.7 |
| Q1 FY2019 | Mar 31, 2019 | 95.7% | +17.9 |
| Q4 FY2018 | Dec 31, 2018 | -25.0% | −48.8 |
| Q3 FY2018 | Sep 30, 2018 | 73.8% | −20.8 |
| Q2 FY2018 | Jun 30, 2018 | 46.3% | +25.5 |
| Q1 FY2018 | Mar 31, 2018 | 77.8% | −4.8 |
| Q4 FY2017 | Dec 31, 2017 | 23.8% | −32.0 |
| Q3 FY2017 | Sep 30, 2017 | 94.6% | +17.1 |
| Q2 FY2017 | Jun 30, 2017 | 20.8% | −54.6 |
| Q1 FY2017 | Mar 31, 2017 | 82.6% | +0.2 |
| Q4 FY2016 | Dec 31, 2016 | 55.9% | −26.9 |
| Q3 FY2016 | Sep 30, 2016 | 77.5% | – |
| Q2 FY2016 | Jun 30, 2016 | 75.4% | – |
| Q1 FY2016 | Mar 31, 2016 | 82.4% | – |
| Q4 FY2015 | Dec 31, 2015 | 82.8% | – |
See a number that looks wrong?